Search / Trial NCT06226844

Can the BeatMove Device Help Patients With Obliterative Arterial Disease of the Lower Limbs?

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Jan 18, 2024

Trial Information

Current as of October 03, 2024

Not yet recruiting

Keywords

Rehabilitation Music Therapy

Description

Atheromatous obliterative arterial disease of the lower limbs at the stage of exertional ischaemia is characterised by intermittent claudication, defined as pain in the lower limbs on walking, forcing the patient to stop for a few minutes after a distance that varies according to the severity of the arterial damage. Physical exercise, and walking training in particular, plays a fundamental role in the management of patients with arterial disease. The beneficial effects of exercise are well known. A recent Cochrane review showed that exercise improves pain-free walking distance and maximum w...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patient with stage II arterial obliteration of the lower limbs (Leriche and Fontaine classification) with exertional claudication
  • * Systolic Pressure Index at the toe \< 0.7 but absolute value \> 30 mmHg
  • * Steno-occlusive lesions on arterial Doppler ultrasound examination of the lower limbs
  • * Patient on an optimised vasculoprotective medical treatment (statin, antiplatelet agent, ACE inhibitor/ARB II)
  • * Patient who is a beneficiary or entitled beneficiary of a health insurance scheme
  • * Patient able to understand, write and read French
  • * Patient who has given free and informed consent
  • Exclusion Criteria:
  • * Patients using walking aids (cane, wheelchair)
  • * Amputation
  • * Patient with a walking perimeter \< 150 m
  • * Hearing or visual impairment
  • * Chronic ischaemia
  • * Trophic disorders
  • * Orthopaedic or vascular MI surgery planned within 3 months
  • * Major cardiovascular co-morbidities (MI \< 3 months or unstable angina)
  • * Pregnant, breast-feeding or parturient women
  • * Patients under court protection, guardianship or curatorship.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0